Ticker Scorecard - CNTA Basics Company: Centessa Pharmaceuticals plc IPO Date: May 28, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.19B Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.51% Avg Daily Range (30 D): $0.48 | 2.93% Avg Daily Range (90 D): $0.44 | 2.64% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .74M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 132 Avg Trade Size (Sh.) (30 D): 103 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 390 Avg Inst. Trade: $1.49M Avg Inst. Trade (30 D): $1.31M Avg Inst. Trade (90 D): $1.18M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.95M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $.86M Avg Closing Volume: 67.54K     News Feb 18, 2025 @ 6:00 PM Hemophilia Market Insights: Key Trends and Develop... Source: Delveinsight Nov 12, 2024 @ 12:00 PM Centessa Pharmaceuticals Reports Financial Results... Source: Centessa Pharmaceuticals Sep 13, 2024 @ 2:34 AM Centessa Pharmaceuticals Announces Pricing of Upsi... Source: N/A Sep 10, 2024 @ 11:00 AM Centessa Announces Positive Interim Phase 1 Clinic... Source: N/A Jun 10, 2024 @ 11:00 AM Centessa Pharmaceuticals Strengthens Executive Lea... Source: Centessa Pharmaceuticals plc Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.52 $-.37 $-.4 Diluted EPS $-1.52 $-.37 $-.4 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -161.27M $ -42.57M $ -43.82M Operating Income / Loss $ -161.65M $ -46.41M $ -43.98M Cost of Revenue $ $ $ Net Cash Flow $ 223.53M $ 267.65M $ 9.15M PE Ratio